← back to search

Ben Ho

SickKids Foundation · CA
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Chromatin Remodeling and Cancer, Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, and Neuroblastoma Research and Treatments.
h-index
14
citations
1,353
works
40
NIH funding
primary concept
Medicine
email

Recent publications

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group
Neuro-Oncology 2025cited by 17position: middledoi
Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children’s Oncology Group Trial ACNS0333
Journal of Clinical Oncology 2020cited by 191position: middledoi
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
Acta Neuropathologica 2020cited by 92position: middledoi
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
Cancer Discovery 2020cited by 84position: middledoi
Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
Neuro-Oncology 2019cited by 229position: firstdoi
The molecular landscape of ETMR at diagnosis and relapse
Nature 2019cited by 144position: middledoi
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
Acta Neuropathologica 2019cited by 115position: middledoi
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Cancer Cell 2019cited by 85position: middledoi
Heterogeneity within the PF-EPN-B ependymoma subgroup
Acta Neuropathologica 2018cited by 129position: middledoi
ATRT-11. MOLECULAR SUBGROUPS OF ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): TOWARDS A CONSENSUS
Neuro-Oncology 2018cited by 2position: middledoi
Genomic landscape of pineoblastoma.
Journal of Clinical Oncology 2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Annie Huang · University of South China6 papers (2018–2025)Franck Bourdeaut · Inserm3 papers (2018–2020)Martin Hasselblatt · University Hospital Münster3 papers (2018–2020)Michael C. Frühwald · Bayer (Germany)3 papers (2018–2020)Maryam Fouladi · University of Cincinnati3 papers (2018–2025)Pascal D. Johann · Bayer (Germany)3 papers (2018–2020)Marcel Kool · European Bioinformatics Institute3 papers (2018–2020)Ian F. Pollack · University of Pittsburgh2 papers (2020–2025)Peter C. Burger · Sidney Kimmel Comprehensive Cancer Center2 papers (2020–2025)Yura Grabovska · Cancer Research Institute of the Slovak Academy of Sciences2 papers (2018–2019) · 2 papers (2019–2020)Fupan Yao · Hospital for Sick Children2 papers (2018–2019)Alyssa Reddy · Mayo Clinic2 papers (2020–2025)Amar Gajjar · Mills Peninsula Health Services2 papers (2020–2025)Alexander R. Judkins · University of Southern California2 papers (2020–2025)Claire Mazewski · Emory University2 papers (2020–2025)Vicky L. Poss · University of Alabama at Birmingham1 papers (2020–2020)J. Russ Geyer · Seattle Children's Hospital1 papers (2025–2025)Fabien Forest · Université Claude Bernard Lyon 11 papers (2018–2018)Michael Bockmayr · Universität Hamburg1 papers (2020–2020)